Navigation Links
Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI
Date:6/2/2009

> 39 degrees C 33.3% (1/3) 40.0% (2/5) ------------------------------------------------------------------------- Albumin ------------------------------------------------------------------------- < =25 mg/mL 22.2% (8/36) 31.5% (17/54) 26-35 mg/mL 10.0% (9/90) 23.3% (20/86) ------------------------------------------------------------------------- Strain Type ------------------------------------------------------------------------- Non-BI (NAP1/027) 7.8% (8/103) 25.5% (27/106) -------------------------------------------------------------------------

Dr. Miller also presented the previously announced top-line results and data related to patient status (in-patient/out-patient), age (under/over 65) and the strain type BI (NAP1/027).

"The subgroup analysis shows that fidaxomicin is more effective than oral vancomycin when it comes to reducing recurrence, even in high risk patient populations such as those older than 65, hospitalized patients, and patients with very low albumin levels," said Mark A. Miller, M.D., Chief of Clinical Microbiology, Head of the Division of Infectious Diseases, Chair of the Infection Prevention and Control Unit at Jewish General Hospital and Associate Professor of Medicine and Microbiology/Immunology at McGill University in Montreal, Quebec, Canada.

Additional analyses from this study will be presented at medical conferences throughout the year.

Fidaxomicin Clinical Study Design

629 adult subjects were enrolled in this multi-center, randomized, double-blind Phase 3 clinical trial, which was the largest such trial for the treatment of CDI. Subjects with confirmed CDI received either 200 mg fidaxomicin dosed orally twice daily or 125 mg Vancocin dosed orally four times daily
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ... June 29, 2015 , ... MediVet ... terms of the agreement, MediVet will acquire the rights to a portfolio of ... currently in pre-clinical development as a potential next-generation treatment for various musculoskeletal and ...
(Date:6/29/2015)... , June 29, 2015  Neuralstem, Inc. (NYSE MKT: ... to develop small molecule and cell therapy treatments for ... been approved for listing on the NASDAQ Capital Market ... continue to trade on the NYSE MKT until the ... NASDAQ Capital Market is expected to commence on July ...
(Date:6/29/2015)... , June 29, 2015 ... and medical information products and services, today announced the ... According to the 2014 Journal Citation Reports® (JCR) published ... Impact Factors increase from 2013 to 2014, ahead of ... occupied the top rank in 62 subject categories, up ...
(Date:6/26/2015)... STRASBURG, Va. , June 26, 2015  A ... release two products made with synthetic rhino horn: beer ... in Vietnam . In response to ... oppose the manufacture, marketing and sale of synthetic rhino ... (IRF) and Save the Rhino International ...
Breaking Biology Technology:MediVet Biologics Acquires Exclusive Patent License from Kansas State University 2MediVet Biologics Acquires Exclusive Patent License from Kansas State University 3Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3Rhino Experts Oppose Synthetic Rhino Horn as Solution to Poaching Crisis 2
... An affiliate of,Phlo Corporation (OTC: PHLC) (the "Company") ... has now been expanded to the San,Francisco and ... counties and stretching to the Oregon border. ... Mollie,Stones Grocery in Palo Alto, Zanotto,s Grocery in ...
... 49%, Pre-Tax Net Income Up 42%, HARBIN, China, ... Bulletin Board: CKGT), a vertically integrated,grower, developer, manufacturer, and ... its report on Form 10QSB and reported its,unaudited results ... reported,are in U.S. dollars. The Company has achieved ...
... connected with potential Benitec HIV therapy, MELBOURNE, Australia, ... Memorandum of Understanding with California-based,CalbaTech, Inc. (OTC Bulletin Board: ... patients who may use the healthy adult (or "blood" ... collaborated with City of Hope, a biomedical research and,treatment ...
Cached Biology Technology:Phlo Affiliate Reports Expanded Coverage to Oregon Border 2China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results 2China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results 3Benitec MOU With CalbaTech, Inc. 2Benitec MOU With CalbaTech, Inc. 3Benitec MOU With CalbaTech, Inc. 4
(Date:6/24/2015)... SAN JOSE, Calif. , June 24, 2015 ... leading developer of human interface solutions, today announced ... fingerprint sensor to provide secure authentication for its ... Having recently reached more than 200 million shipments ... shipment with Sharp reinforces Synaptics, strength, scalability and ...
(Date:6/23/2015)... RALEIGH, N.C. , June 23, 2015 /PRNewswire/ ... technology, today announced the results of a recent ... unmatched accuracy on the wrist during activity. In ... biometric technology was compared along with the Apple ... for accurately measuring heart rate during activity. The ...
(Date:6/17/2015)... Germany , June 17, 2015 ... QIA) today launched new Investigator ® STR assay kits ... the United States . The new genetic fingerprint ... genomic markers (short tandem repeats or STRs) for DNA matching. ... the quality of DNA in each sample, a novel QIAGEN ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... found a mechanism that naturally shuts down cellulose production ... turned on may be key to enhancing biomass production ... botany and plant pathology, said that small-interfering RNAs (siRNAs) ... off genes involved in primary cell wall growth in ...
... Finnish scientists have reported a breakthrough in the attempts ... discovered disturbances in lipid and amino acid metabolism in ... known as juvenile diabetes. The alterations preceded the autoimmune ... new approaches for prediction and prevention of type 1 ...
... is available in French . , ... intelligent design. An evolutionary geneticist from the Universit de ... Lyon and Montpellier, have published a ground-breaking study that ... LUCA (Last Universal Common Ancestor). Their findings, presented in ...
Cached Biology News:Researchers find nature's shut-off switch for cellulose production 2New scientific knowledge on juvenile diabetes 2New scientific knowledge on juvenile diabetes 3Earth's original ancestor was LUCA, not Adam nor Eve 2